Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Notarangelo

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Human Mutation|January 1, 1994
C to T mutation causing premature termination of CD40 ligand at amino acid 221 in a patient affected by hyper IgM syndromeA Villa, D Strina, P Macchi, et al.
Immunodeficiency|January 1, 1993
Molecular analysis of X-linked immunodeficiency with hyper-IgM and X-linked lymphoproliferative syndromeL D Notarangelo, E Mantuano, S Bione, et al.
Annals of Allergy|September 1, 1993
Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disordersS Guarnaccia, C C Kurman, L D Notarangelo, et al.
Human Genetics|December 1, 1991
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WASL D Notarangelo, O Parolini, F Porta, et al.
Immunological Reviews|April 1, 1994
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)"R A Kroczek, D Graf, D Brugnoni, et al.
Human Genetics|May 1, 1992
Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 betaG de Saint Basile, L D Notarangelo, C Bonaiti-Pellié, et al.
Cancer Gene Therapy|November 4, 2000
Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndromeM G Sacco, M Ungari, E M Catò, et al.
The American Journal of Surgical Pathology|February 16, 1999
The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the diseaseW Vermi, L Blanzuoli, M D Kraus, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2001
Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor familyJ Lewis, L J Eiben, D L Nelson, et al.
The Journal of Experimental Medicine|August 8, 2001
NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseaseC Bottino, M Falco, S Parolini, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Human Mutation|January 1, 1994
C to T mutation causing premature termination of CD40 ligand at amino acid 221 in a patient affected by hyper IgM syndromeA Villa, D Strina, P Macchi, et al.
Immunodeficiency|January 1, 1993
Molecular analysis of X-linked immunodeficiency with hyper-IgM and X-linked lymphoproliferative syndromeL D Notarangelo, E Mantuano, S Bione, et al.
Annals of Allergy|September 1, 1993
Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disordersS Guarnaccia, C C Kurman, L D Notarangelo, et al.
Human Genetics|December 1, 1991
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WASL D Notarangelo, O Parolini, F Porta, et al.
Immunological Reviews|April 1, 1994
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)"R A Kroczek, D Graf, D Brugnoni, et al.
Human Genetics|May 1, 1992
Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 betaG de Saint Basile, L D Notarangelo, C Bonaiti-Pellié, et al.
Cancer Gene Therapy|November 4, 2000
Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndromeM G Sacco, M Ungari, E M Catò, et al.
The American Journal of Surgical Pathology|February 16, 1999
The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the diseaseW Vermi, L Blanzuoli, M D Kraus, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2001
Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor familyJ Lewis, L J Eiben, D L Nelson, et al.
The Journal of Experimental Medicine|August 8, 2001
NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseaseC Bottino, M Falco, S Parolini, et al.
Pageof 17